Thermo Fisher Scientific Inc (N:TMO)

Business Focus: Advanced Medical Equipment & Technology

Apr 02, 2024 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2024
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2024 before the market opens on Wednesday, April 24, 2024, and will hold a conference call on the same day at 8:30 a.m. EDT.
Mar 01, 2024 08:00 am ET
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously announced tender offer (the “Offer") to acquire all of the outstanding common shares (“Shares”) and all of the outstanding American Depositary Shares, each representing one Share (“ADSs” and, together with the Shares, the “Offer Securities”), of Olink Holding AB (publ) (“Olink”) for $26.00 per Share and per ADS, in cash.
Feb 28, 2024 08:00 am ET
Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen Health Care Conference on Wednesday, March 6, 2024 at 9:10 a.m. (EST).
Feb 21, 2024 05:00 pm ET
Thermo Fisher Scientific Increases Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on April 15, 2024, to shareholders of record as of March 15, 2024. This reflects an 11% increase over the previous dividend payment of $0.35.
Jan 31, 2024 06:00 am ET
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2023.
Jan 30, 2024 09:15 am ET
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
FN Media Group News Commentary - Recent reports show that the Multiple myeloma Diagnostic market will continue to grow in the next several years. Multiple myeloma is a type of plasma cell cancer. Normal plasma cells are recognized as an important...
Jan 04, 2024 08:00 am ET
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously announced tender offer (the “Offer”) to acquire all of the outstanding common shares (“Shares”) and all of the outstanding American Depositary Shares, each representing one Share (“ADSs” and, together with the Shares, the “Offer Securities”), of Olink Holding AB (publ) (“Olink”) for $26.00 per Share and per ADS, in cash.
Jan 03, 2024 08:00 am ET
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 11:15 a.m. (EST).
Jan 02, 2024 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, January 31, 2024
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2023 before the market opens on Wednesday, January 31, 2024, and will hold a conference call on the same day at 8:30 a.m. EST.
Dec 15, 2023 08:00 am ET
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously announced tender offer (the “Offer") to acquire all of the outstanding common shares (“Shares”) and all of the outstanding American Depositary Shares, each representing one Share (“ADSs” and, together with the Shares, the “Offer Securities”), of Olink Holding AB (publ) (“Olink”) for $26.00 per Share and per ADS, in cash.
Dec 06, 2023 03:00 am ET
Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 15-year virtual power purchasing agreement (VPPA) with international solar developer
Dec 01, 2023 08:00 am ET
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously announced tender offer (the “Offer") to acquire all of the outstanding common shares (“Shares”) and all of the outstanding American Depositary Shares, each representing one Share (“ADSs” and, together with the Shares, the “Offer Securities”), of Olink Holding AB (publ) (“Olink”) for $26.00 per Share and per ADS, in cash.
Nov 28, 2023 08:13 pm ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes:
Nov 28, 2023 08:00 am ET
Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic partnership to develop and commercially scale multiproduct platforms on an accelerated basis.
Nov 14, 2023 08:00 am ET
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company’s existing repurchase authorization, of which $1 billion was remaining.
Nov 09, 2023 05:00 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.35 per common share, payable on January 16, 2024, to shareholders of record as of December 15, 2023.
Oct 31, 2023 08:43 am ET
Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions, today announced that Thermo Fisher has commenced the previously announced tender offer (the “Offer") through a direct, wholly owned subsidiary of Thermo Fisher (the “Buyer”) to acquire all of the outstanding common shares and all of the outstanding American Depositary Shares (“ADSs”) of Olink for $26.00 per common share and per ADS, in cash.
Oct 25, 2023 06:00 am ET
Thermo Fisher Scientific Reports Third Quarter 2023 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 30, 2023.
Oct 17, 2023 08:19 am ET
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions, today announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share (ADS) in cash. This represents a premium of approximately 74% to the closing price of Olink’s American Depositary Shares that trade on NASDAQ on October 16, 2023, the last trading day prio
Oct 03, 2023 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 25, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2023 before the market opens on Wednesday, October 25, 2023, and will hold a conference call on the same day at 8:30 a.m. EDT.
Sep 07, 2023 08:00 am ET
Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organization, today announced a collaboration to help bring clinical research to historically underserved patient populations through NMQF’s Alliance for Representative Clinical Trials (ARC). The collaboration supports biopharmaceutical and biotech customers in meeting regulatory expectations to enroll and retain patients in clinical trials who more fully reflect real-world populations experiencing the disease or he
Sep 06, 2023 08:00 am ET
Thermo Fisher Scientific to Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 13, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023 at 8:50 a.m. (EDT).
Aug 25, 2023 08:00 am ET
Thermo Fisher Scientific to Present at Handelsbanken 3rd Annual Life Science Innovation Day on August 30th, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Handelsbanken 3rd Annual Life Science Innovation Day on Wednesday, August 30th, 2023 at 10:00 a.m. (EDT).
Aug 14, 2023 04:10 pm ET
Thermo Fisher Scientific Completes Acquisition of CorEvitas
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed the acquisition of CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity (“Audax”), for $912.5 million in cash. Thermo Fisher announced the agreement to acquire CorEvitas on
Aug 07, 2023 08:15 pm ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.95 billion aggregate principal amount (the “Offering”) of the following notes, each issued at par:
Jul 26, 2023 06:00 am ET
Thermo Fisher Scientific Reports Second Quarter 2023 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 1, 2023.
Jul 13, 2023 05:00 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.35 per common share, payable on October 13, 2023, to shareholders of record as of September 15, 2023.
Jul 13, 2023 04:30 pm ET
Thermo Fisher Scientific Elects New Director to Board
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Jenny Johnson, president and chief executive officer of Franklin Resources, Inc. (NYSE:BEN), has been elected to its board of directors. The appointment brings the total number of Thermo Fisher board members to 12.
Jul 06, 2023 08:00 am ET
Thermo Fisher Scientific to Acquire CorEvitas
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity (“Audax”), for $912.5 million in cash.
Jul 05, 2023 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2023 before the market opens on Wednesday, July 26, 2023, and will hold a conference call on the same day at 8:30 a.m. EDT.
Jun 05, 2023 08:00 am ET
Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer to Revolutionize Biological Discovery
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer, one of the most significant advancements in mass spectrometry in 15 years. The new Astral analyzer
May 24, 2023 05:00 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.35 per common share, payable on July 14, 2023, to shareholders of record as of June 15, 2023.
May 24, 2023 08:30 am ET
Thermo Fisher Scientific Hosts 2023 Investor Day
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its 2023 Investor Day today and provided an in-depth review of the Company’s proven growth strategy and its industry-leading businesses: Life Science Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Products and Biopharma Services.
May 22, 2023 08:00 am ET
Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Bernstein 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023 at 11:00 a.m. (EDT).
May 19, 2023 08:00 am ET
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays to Aid in the Risk Assessment of Preeclampsia
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR novel biomarkers, the first and only immunoassays to receive breakthrough designation and clearance for the risk assessment and clinical management of preeclampsia, a severe pregnancy complication.
May 17, 2023 08:00 am ET
Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report. The report highlights the company’s commitment to society and stakeholders and provides insight into its CSR progress and environmental, social and governance (ESG) efforts.
May 09, 2023 08:15 am ET
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets 
Pfizer and Thermo Fisher Scientific Inc. (NYSE: TMO) today announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable. Access to local NGS testing can help to provide faster analysis of associated genes, empowering healthcare providers to select the right therapy for that individual patient.1
May 02, 2023 08:00 am ET
Thermo Fisher Scientific to Present at BofA Securities 2023 Healthcare Conference on May 10th, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2023 Healthcare Conference on Wednesday, May 10, 2023 at 11:00 a.m. (EDT).
Apr 28, 2023 07:00 am ET
ASLAN Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced financial results for the first quarter ended March 31, 2023,...
Apr 26, 2023 06:00 am ET
Thermo Fisher Scientific Reports First Quarter 2023 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 1, 2023.
Apr 10, 2023 08:00 am ET
Thermo Fisher Scientific to Host Investor Day
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2023 Investor Day on Wednesday, May 24, starting at 9:00 a.m. (ET)in New York City.
Apr 04, 2023 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2023 before the market opens on Wednesday, April 26, 2023, and will hold a conference call on the same day at 8:30 a.m. EST.
Mar 27, 2023 04:30 pm ET
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.
Mar 24, 2023 07:00 am ET
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced financial results for the fourth quarter and full year ended...
Mar 16, 2023 05:00 pm ET
GeminiBio Appoints Industry Veteran Cory Stevenson as Executive Chairman
FORT LAUDERDALE, Fla. and Sacramento, Calif., March 16, 2023 /PRNewswire/ -- Gemini BioProducts Holding, Inc. ("GeminiBio" or the "Company"), a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Florida-based healthcare private equity firm, announced the appointment of Cory Stevenson as Executive Chairman of the Board of Directors.
Feb 28, 2023 08:00 am ET
Thermo Fisher Scientific to Present at Cowen 43rd Annual Healthcare Conference on March 6, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Cowen Healthcare Conference on Monday, March 6, 2023 at 9:10 a.m. (EST).
Feb 22, 2023 04:30 pm ET
Thermo Fisher Scientific Increases Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per common share payable on April 14, 2023, to stockholders of record as of March 15, 2023. This reflects a 17% increase over the previous dividend payment of $0.30.
Feb 02, 2023 08:00 am ET
Thermo Fisher Scientific to Power All Current U.S. Sites With 100 Percent Renewable Electricity
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it will power all of the company’s current U.S. sites with 100 percent renewable electricity by 2026. The company’s new 20-year virtual power purchasing agreement with EDF Renewables includes the full output of the 200-megawatt (MW) Millers Branch Solar proje
Feb 01, 2023 08:34 am ET
Thinking about trading options or stock in Advanced Micro Devices, Tesla, Alibaba, Thermo Fisher Scientific, or TransUnion?
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD, TSLA, BABA, TMO, and TRU.
Feb 01, 2023 06:00 am ET
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2022 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2022.
Jan 04, 2023 08:00 am ET
Thermo Fisher Scientific to Present at 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 10:30 a.m. (EST).
Jan 03, 2023 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 1, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2022 before the market opens on Wednesday, February 1, 2023, and will hold a conference call on the same day at 8:30 a.m. EST.
Jan 03, 2023 07:08 am ET
Thermo Fisher Scientific Completes Acquisition of The Binding Site Group
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of The Binding Site Group (“The Binding Site”), a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at £2.3 billion, or $2.8 billion at current exchange rates. Thermo Fisher announced the agreement to acquire The Binding Site on
Jan 03, 2023 07:00 am ET
ASLAN Pharmaceuticals and Thermo Fisher Scientific Announce Partnership to Manufacture High Concentration Formulation of Eblasakimab for Future Studies
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, and Thermo Fisher Scientific Inc (NYSE: TMO), the world leader in serving...
Dec 06, 2022 08:00 am ET
Thermo Fisher Scientific Raises Greenhouse Gas Emissions Reduction Target on Path to Net-zero Emissions
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a new 2030 greenhouse gas emissions reduction target to reduce its Scope 1 and 2 emissions from operations by more than 50% from a 2018 baseline.1 The company is on track to achieve its previous 2030 goal of a
Nov 21, 2022 08:00 am ET
Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 10:30 a.m. (EST).
Nov 15, 2022 04:05 pm ET
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that on November 14, 2022 it priced an offering of €1.25 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes:
Nov 15, 2022 04:00 pm ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that on November 14, 2022 it priced an offering of $1.2 billion aggregate principal amount (the “Offering”) of the following notes:
Nov 10, 2022 04:35 pm ET
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.
Nov 10, 2022 04:30 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on January 16, 2023, to shareholders of record as of December 15, 2022.
Nov 03, 2022 08:00 am ET
Oct 31, 2022 07:05 am ET
Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today provided an update on capital deployment.
Oct 31, 2022 07:00 am ET
Thermo Fisher Scientific to Acquire The Binding Site Group
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at £2.25 billion, or $2.6 billion at current exchange rates.
Oct 26, 2022 08:00 am ET
MasterControl Honors Customers’ Achievements in Quality, Manufacturing, Analytics and Innovation at the Annual Masters of Excellence Gala.
MasterControl, a provider of quality and manufacturing software solutions that enable life sciences and other regulated companies to deliver life-changing products to more people sooner, announced the 2022 Masters of Excellence Awards winners. The...
Oct 26, 2022 06:00 am ET
Thermo Fisher Scientific Reports Third Quarter 2022 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 1, 2022.
Oct 14, 2022 08:21 am ET
Thermo Fisher Scientific Prices Offering of Yen-Denominated Senior Notes
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) the world leader in serving science, announced today that it has priced an offering of ¥109.5 billion aggregate principal amount (the “Offering”) of the following yen-denominated notes, each issued at par:
Oct 04, 2022 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2022 before the market opens on Wednesday, October 26, 2022, and will hold a conference call on the same day at 8:30 a.m. EDT.
Sep 29, 2022 08:00 am ET
Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, recently signed an eight-year virtual power purchasing agreement with Enel North America to deliver a 90-megawatt (MW) portion of the Seven Cowboy wind project in western Oklahoma. Thermo Fisher will purchase approximately 400,000 megawatt hours (MWh) of renewable electricity, equal to half of the company’s current U.S. electricity needs.
Sep 07, 2022 08:00 am ET
Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 2022 Global Healthcare Conference on Monday, September 12, 2022, at 9:55 a.m. (EDT).
Aug 03, 2022 08:00 am ET
Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis
Thermo Fisher Scientific Inc., the world leader in serving science, and Structura Biotechnology Inc., a leading provider of cryo-EM data analysis software, today announced a collaboration to make available a new single particle analysis software solution, a version of Structura’s CryoSPARC Live, that is designed to integrate with Thermo Fisher’s Smart EPU software and cryo-transmission electron microscope (cryo-TEM) technology. The new solution,
Jul 28, 2022 06:00 am ET
Thermo Fisher Scientific Reports Second Quarter 2022 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 2, 2022.
Jul 07, 2022 04:30 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on July 7, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on October 14, 2022, to shareholders of record as of September 15, 2022.
Jul 05, 2022 09:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2022
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2022 before the market opens on Thursday, July 28, 2022, and will hold a conference call on the same day at 8:30 a.m. EDT.
Jun 06, 2022 08:00 am ET
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, is showcasing new instruments, workflows, software and industry collaborations that enable customers to generate new analytical insights and accelerate next generation vaccine and therapy development. The company will showcase these innovations during the 70th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, being held June 5-9, 2022, in the Minneapolis Convention Center, Minneapolis.
Jun 02, 2022 08:00 am ET
Thermo Fisher Scientific Releases Corporate Social Responsibility Report
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report. The report highlights the company’s commitment to society and stakeholders providing detailed insight into the company’s CSR progress and environmental, social and governance (ESG) efforts.
May 19, 2022 09:00 am ET
Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on May 18, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on July 15, 2022, to shareholders of record as of June 15, 2022.
May 06, 2022 08:00 am ET
Thermo Fisher Scientific to Present at BofA Securities 2022 Healthcare Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 12:20 p.m. (EDT).
Apr 28, 2022 06:00 am ET
Thermo Fisher Scientific Reports First Quarter 2022 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2022.
Apr 11, 2022 08:00 am ET
Thermo Fisher Scientific to Host Investor Day
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2022 Investor Day on Wednesday, May 18, starting at 9:00 a.m. (ET), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City.
Apr 05, 2022 04:05 pm ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 28, 2022
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2022 before the market opens on Thursday, April 28, 2022, and will hold a conference call on the same day at 8:30 a.m. EST.
Mar 02, 2022 08:00 am ET
Thermo Fisher Scientific to Present at Cowen’s 42nd Annual Healthcare Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at Cowen’s 42nd Annual Conference on Monday, March 7, 2022, at 10:30 a.m. (EST).
Feb 23, 2022 06:00 pm ET
Thermo Fisher Scientific Elects New Director to Board
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Ruby Chandy has been elected to its board of directors, effective March 1, 2022. Ms. Chandy’s appointment will bring the total number of Thermo Fisher board members to 13.
Feb 23, 2022 05:30 pm ET
Thermo Fisher Scientific Increases Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.30 per common share, payable on April 14, 2022, to shareholders of record as of March 16, 2022. This reflects a 15% increase over the previous dividend payment of $0.26.
Feb 23, 2022 08:00 am ET
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the U.S. of Spikevax®, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline.
Feb 08, 2022 08:30 am ET
New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis
Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific discovery. To further enable customers’ cutting-edge research in areas such as gene editing and infectious disease, Thermo Fisher Scientific introduced the new
Feb 07, 2022 08:51 am ET
Thermo Fisher Scientific Partners with Medidata Acorn AI to Optimize Clinical Research Site Selection and Speed Patient Enrollment in Clinical Trials
Thermo Fisher Scientific Inc., the world leader in serving science, announced a multiyear partnership with Medidata Acorn AI, a Dassault Systèmes company leading the digital transformation of life sciences. Through this partnership, the PPD clinical research business of Thermo Fisher has collaborated with Medidata to develop PPD TrueCast, a comprehensive enterprise application combining extensive patient recruitment and site performance data with predictive models and advanced analytics. Offering one of the industry’s most wide-ranging representations of real-time site performance combined wit
Feb 07, 2022 08:00 am ET
Thermo Fisher Scientific Launches Rapid Environmental PCR Testing Solution That Detects In-Air SARS-CoV-2 Pathogens
Thermo Fisher Scientific Inc., today announced the launch of a new rapid environmental test to help in the fight against COVID-19. The Thermo Scientific Renvo Rapid PCR Test is the latest solution in the company’s in-air pathogen surveillance product portfolio. The Renvo Rapid PCR Test is performed on air samples collected
Feb 02, 2022 05:00 am ET
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2021 Results
WALTHAM, Mass., Feb. 2, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2021.
Jan 27, 2022 03:05 pm ET
Thermo Fisher Scientific Earns Top Score for LGBTQ+ Workplace Equality for Seventh Consecutive Year
WALTHAM, Mass., Jan. 27, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, received a score of 100 on the Human Rights Campaign Foundation's 2022 Corporate Equality Index (CEI) for the seventh consecutive year. As the national benchmarking tool measuring policies, practices and benefits pertinent to lesbian, gay, bisexual, transgender and queer (LGBTQ) employees, the CEI is a driving force for LGBTQ+ workplace inclusion.
Jan 10, 2022 10:30 am ET
New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024
VANCOUVER, BC, Jan. 10, 2022 /PRNewswire/ -- USA News Group  -  Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as leukemia, lymphoma and myeloma. According to analysts at Markets and Markets, the leukemia therapeutics market is projected to reach US$17.1 billion by 2024, growing at a CAGR of 6.8%. Along the way, there have been several positive developments in the fight against blood cancers including more recent updates from Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), AbbVie Inc. (NYSE:ABBV), Novartis AG (NYSE:NVS), Thermo Fisher Scientific Inc.
Jan 05, 2022 07:00 am ET
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins
WALTHAM, Mass., Jan. 5, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash purchase price of approximately $1.85 billion.
Jan 04, 2022 07:00 am ET
Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 4, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. (EST).  Among other topics, Mr. Casper will provide the company's current perspective on its business and expectations for future financial performance. 
Jan 03, 2022 03:00 pm ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 2, 2022
WALTHAM, Mass., Jan. 3, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2021 before the market opens on Wednesday, February 2, 2022, and will hold a conference call on the same day at 8:30 a.m. EST.
Dec 30, 2021 03:05 pm ET
Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference
WALTHAM, Mass., Dec. 30, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 2022 Goldman Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, at 9:00 a.m. (EDT). 
Dec 08, 2021 07:45 am ET
Thermo Fisher Scientific Completes Acquisition of PPD, Inc.
WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.
Nov 29, 2021 12:00 am ET
Thermo Fisher Scientific Confirms Detection of SARS-CoV-2 in Samples Containing the Omicron Variant with its TaqPath COVID-19 Tests
WALTHAM, Mass., Nov. 29, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit*, which test for the presence of SARS-CoV-2, are not impacted by the emerging B.1.1.529, or Omicron variant, enabling accurate test results.
Nov 18, 2021 07:00 am ET
Thermo Fisher Scientific Announces Redemption of Senior Notes
WALTHAM, Mass., Nov. 18, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it is giving notice of its intention to redeem the following Senior Notes (the "Redemption"), representing an aggregate total principal amount of approximately $2.2 billion, on December 3, 2021 (the "Redemption Date"):
Nov 09, 2021 03:10 pm ET
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
WALTHAM, Mass., Nov. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of €2.8 billion aggregate principal amount (the "Offering") of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly owned finance subsidiary:
Nov 04, 2021 07:19 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., Nov. 4, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on January 14, 2022, to shareholders of record as of December 15, 2021.
Nov 01, 2021 08:52 am ET
Thermo Fisher Scientific Launches New Mass Spectrometry and Chromatography Solutions at ASMS 2021
PHILADELPHIA, Nov. 1, 2021 /PRNewswire/ -- ASMS 2021 –Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is empowering scientists to drive groundbreaking discoveries with the introduction of new-generation mass spectrometry instruments, workflows and software. The company will showcase new additions to its industry-leading offering during the 69th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, being held October 31-November 4, in the Pennsylvania Convention Center, Philadelphia, Pennsylvania.
Oct 27, 2021 09:31 am ET
Thinking about trading options or stock in Thermo Fisher Scientific, Bristol-Myers Squibb, Sony, General Dynamics, or NVIDIA?
NEW YORK, Oct. 27, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TMO, BMY, SONY, GD, and NVDA.
Oct 27, 2021 06:00 am ET
Thermo Fisher Scientific Reports Third Quarter 2021 Results
WALTHAM, Mass., Oct. 27, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 2, 2021.
Oct 26, 2021 08:00 am ET
Thermo Fisher Scientific Publishes 2020 Corporate Social Responsibility Report
WALTHAM, Mass., Oct. 26, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published its 2020 Corporate Social Responsibility (CSR) report, reflecting its commitment to society, stakeholders and environmental, social and governance (ESG) efforts. The report provides detailed insight into the company's approach to CSR, outlines future priorities and highlights achievements across four pillars of focus: operations, colleagues, communities and environment.
Oct 20, 2021 09:31 am ET
Thinking about trading options or stock in Abbott Laboratories, Square, Thermo Fisher Scientific, Bilibili, or Tesla?
NEW YORK, Oct. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ABT, SQ, TMO, BILI, and TSLA.
Oct 19, 2021 08:36 pm ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
WALTHAM, Mass., Oct. 19, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of $5.85 billion aggregate principal amount (the "Offering") of the following notes, each issued at par:
Oct 19, 2021 08:00 am ET
Thermo Fisher Scientific Announces Offering of USD-Denominated Senior Notes
WALTHAM, Mass., Oct. 19, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it intends to offer (the "Offering") USD-denominated senior notes (the "Notes").
Oct 11, 2021 04:00 pm ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 27, 2021
WALTHAM, Mass., Oct. 11, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2021 before the market opens on Wednesday, October 27, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.
Oct 06, 2021 06:20 pm ET
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
WALTHAM, Mass., Oct. 6, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of €5.25 billion aggregate principal amount (the "Offering") of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly owned finance subsidiary:
Oct 01, 2021 06:00 am ET
Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland
WALTHAM, Mass., Oct. 1, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland as part of its strategic partnership with CSL Limited announced last year. The Lengnau site will become part of Thermo Fisher's global biologics manufacturing network, and approximately 200 employees will join Thermo Fisher.
Sep 29, 2021 08:00 am ET
Thermo Fisher Scientific Continues Support for COVID-19 Testing on Historically Black College and University Campuses
WALTHAM, Mass., Sept. 29, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE:TMO) the world leader in serving science, today announced continuing support for The Just Project, a national initiative to provide COVID-19 testing to students, faculty and staff across more than 60 historically black colleges and universities (HBCUs) at no cost. A $7.5 million commitment for the 2021-2022 school year will once again provide diagnostic instruments, test kits and related supplies.
Sep 23, 2021 04:05 pm ET
Thermo Fisher Scientific Authorizes $3 Billion of Share Repurchases
WALTHAM, Mass., Sept. 23, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $3 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company's existing repurchase authorization, of which $500 million was remaining.
Sep 21, 2021 08:00 am ET
Thermo Fisher Scientific to Present at the JP Morgan 12th Annual U.S. All Stars Conference on September 22, 2021
WALTHAM, Mass., Sept. 21, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the JP Morgan 12th Annual U.S. All Stars Conference on Wednesday, September 22, 2021 at 9:00 a.m. (EDT). 
Sep 20, 2021 09:31 am ET
Thinking about trading options or stock in AMC Entertainment, Plug Power, Palantir Technologies, Advanced Micro Devices, or Thermo Fisher Scientific?
NEW YORK, Sept. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, PLUG, PLTR, AMD, and TMO.
Sep 20, 2021 08:00 am ET
Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities
WALTHAM, Mass., Sept. 20, 2021 /PRNewswire/ -- Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.
Sep 09, 2021 04:33 pm ET
Thermo Fisher Scientific to Host Virtual Investor Day
WALTHAM, Mass., Sept. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host a virtual Investor Day on Friday, September 17, 2021, starting at 9:00 a.m. and expected to conclude by 11:00 a.m. (EDT).
Sep 02, 2021 08:00 am ET
Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing
WALTHAM, Mass., Sept. 2, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a $192.5 million contract award from the U.S. Department of Defense (DoD) to ensure reliable domestic production of pipette tips, which are used within research and diagnostic labs to dispense precise amounts of liquid. In mid-2020, the company announced its own investments to increase pipette tip production capacity to support COVID-19 testing.
Aug 09, 2021 06:10 pm ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
WALTHAM, Mass., Aug. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of $3.1 billion aggregate principal amount (the "Offering") of the following notes:
Aug 09, 2021 08:38 am ET
Thermo Fisher Scientific Announces Offering of USD-Denominated Senior Notes
WALTHAM, Mass., Aug. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it intends to offer USD-denominated senior notes.
Jul 27, 2021 06:00 am ET
Thermo Fisher Scientific Commits to Achieve Net-Zero Carbon Emissions by 2050
WALTHAM, Mass., July 27, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its commitment to achieve net-zero carbon emissions by 2050. This supports the global goals of the Paris Climate Agreement and the United Nations' Race To Zero campaign and will further advance the company's current strategy to mitigate its impact on the environment.
Jul 15, 2021 08:00 am ET
Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility in Carlsbad, California
WALTHAM, Mass., July 15, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
Jul 13, 2021 07:00 am ET
Thermo Fisher Scientific and My Green Lab Collaborate to Expand Use of ACT Label in Driving Environmentally Sustainable Lab Practices
WALTHAM, Mass., July 13, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of its collaboration with My Green Lab, a non-profit organization committed to improving the environmental sustainability of scientific research. The company has set a goal to obtain Accountability, Consistency and Transparency (ACT) labelling for its entire cold temperature storage portfolio by the end of 2021. Over time, Thermo Fisher expects to ACT label more than 1,200 additional SKUs, enabling research, pharmaceutical and clinical labo
Jul 08, 2021 05:00 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., July 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on October 15, 2021, to shareholders of record as of September 15, 2021.
Jul 07, 2021 04:00 pm ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 28, 2021
WALTHAM, Mass., July 7, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2021 before the market opens on Wednesday, July 28, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.
Jul 07, 2021 09:00 am ET
Thermo Fisher Scientific Expands Corporate Leadership Team
WALTHAM, Mass., July 7, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer (CMO) and will be succeeded by Karen E. Nelson, previously president of the J. Craig Venter Institute. Both will join the company leadership team in August 2021.
Jul 07, 2021 08:00 am ET
Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics
SAN JOSE, Calif. and DAVIS, Calif., July 7, 2021 /PRNewswire/ -- Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving science, and the University of California, Davis (UC Davis) West Coast Metabolomics Center today announced The Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations, best practices and standard operating procedures to support the rapid scale-up of large cohort studies and clinical research.
Jun 08, 2021 04:12 pm ET
Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021
WALTHAM, Mass., June 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT).
Apr 16, 2021 12:48 pm ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PPD, Inc. Buyout
Rigrodsky Law, P.A. announces that it is investigating PPD, Inc. (“PPD”) (NASDAQ GS: PPD) regarding possible breaches of fiduciary duties and other violations of law related to PPD’s agreement to be acquired by Thermo Fisher Scientific Inc....
Apr 15, 2021 01:38 pm ET
PPD ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PPD and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of PPD, Inc. (NASDAQ: PPD) breached their fiduciary duties or violated the federal securities laws in...
Feb 26, 2021 07:00 am ET
Thermo Fisher Scientific Completes Acquisition of Mesa Biotech
WALTHAM, Mass., Feb. 26, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company.
Feb 24, 2021 03:47 pm ET
Thermo Fisher Scientific to Present at 41st Annual Cowen Healthcare Conference on March 3, 2021
WALTHAM, Mass., Feb. 24, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 41st Annual Cowen Healthcare Conference on Wednesday, March 3, 2021, at 10:20 a.m. (EDT). 
Feb 23, 2021 04:00 pm ET
Thermo Fisher Scientific Increases Quarterly Dividend
WALTHAM, Mass., Feb. 23, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on April 16, 2021, to shareholders of record as of March 16, 2021. This reflects an 18% increase over the previous dividend payment of $0.22.
Feb 17, 2021 07:00 am ET
Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs
WALTHAM, Mass., Feb. 17, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently introduced Bigfoot Spectral Cell Sorter and approximately 40 employees will become part of Thermo Fisher's Biosciences business. Propel Labs will continue to operate as a separate entity and serve its existing customers.
Feb 11, 2021 07:00 am ET
Thermo Fisher Scientific Invests $25 Million to Support Black Communities and Businesses in the U.S.
WALTHAM, Mass., Feb. 11, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has committed to investing up to $25 million in minority-serving financial institutions.
Feb 01, 2021 05:00 am ET
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2020 Results
WALTHAM, Mass., Feb. 1, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2020.
Jan 29, 2021 07:00 am ET
Thermo Fisher Scientific Named "Best Place to Work for LGBTQ Equality" for Sixth Consecutive Year
WALTHAM, Mass., Jan. 29, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a "Best Place to Work for LGBTQ Equality" for the sixth consecutive year. The company received a perfect score on the 2021 Corporate Equality Index (CEI), the Human Rights Campaign Foundation's 19th annual scorecard on lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality.
Jan 19, 2021 07:00 am ET
Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech
WALTHAM, Mass., Jan. 19, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction.
Jan 15, 2021 05:30 am ET
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
WALTHAM, Mass. and LYON, France, Jan. 15, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, today announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing business in Belgium for approximately €725 million in cash.
Jan 06, 2021 07:00 am ET
Thermo Fisher Scientific Offers Financial Flexibility with New Managed Equipment Solutions
WALTHAM, Mass., Jan. 6, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of Managed Equipment Solutions, a new subscription-based offering that bundles instrument and equipment procurement with consumables, applications support, software, training and extended service in a convenient and cost-efficient agreement.
Jan 06, 2021 07:00 am ET
Thermo Fisher Scientific to Present at 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
WALTHAM, Mass., Jan. 6, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021, at 3:40 p.m. (EDT).  Among other topics, Mr. Casper will provide the company's current perspective on the impact of the COVID-19 pandemic and expectations for future financial performance.
Jan 05, 2021 03:01 pm ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Monday, February 1, 2021
WALTHAM, Mass., Jan. 5, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2020 before the market opens on Monday, February 1, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.
Dec 30, 2020 03:05 pm ET
Thermo Fisher Scientific Announces Redemption of Senior Notes
WALTHAM, Mass., Dec. 30, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on December 31, 2020, it will give notice of its intention to redeem the following Senior Notes, representing an aggregate total principal amount of approximately $2.6 billion, on January 15, 2021 (the "Redemption Date"):
Nov 30, 2020 07:00 am ET
Thermo Fisher Scientific to Present at the Evercore ISI HealthCONx Conference on December 1, 2020
WALTHAM, Mass., Nov. 30, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Evercore ISI HealthCONx Conference on Tuesday, December 1, 2020, at 1:00 p.m. (EST).  Among other topics, Mr. Casper will provide the company's current perspective on the impact of the COVID-19 pandemic and expectations for future financial performance.
Nov 20, 2020 03:05 pm ET
Thermo Fisher Scientific Elects New Director to Board
WALTHAM, Mass., Nov. 20, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has elected R. Alexandra "Alex" Keith to its board of directors. Ms. Keith's appointment brings the company's total number of board members to 13.
Nov 17, 2020 07:00 am ET
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
WASHINGTON, Nov. 17, 2020 /PRNewswire/ -- Seven leading diagnostics companies and laboratory service providers have formed the Access to Comprehensive Genomic Profiling Coalition (ACGP). The goal of the organization is to collectively advocate for appropriate broad U.S. health insurance coverage of comprehensive genomic profiling (CGP) for patients living with advanced cancer. The current members of ACGP are Exact Sciences (NASDAQ: EXAS), Foundation Medicine, Illumina (NASDAQ: ILMN), LabCorp (NYSE: LH), QIAGEN (NYSE: QGEN), Roche Diagnostics (SIX: RO, ROG: OTCQX: RHHBY), and Thermo Fisher Sc
Nov 06, 2020 05:00 am ET
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
WALTHAM, Mass. and SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022.
Nov 05, 2020 04:30 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases
WALTHAM, Mass., Nov. 5, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.22 per share. The dividend will be paid on January 15, 2021, to shareholders of record as of December 15, 2020.
Oct 21, 2020 06:00 am ET
Thermo Fisher Scientific Reports Third Quarter 2020 Results
WALTHAM, Mass., Oct. 21, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2020.
Oct 19, 2020 08:00 am ET
Thermo Fisher Scientific Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell
WALTHAM, Mass., Oct. 19, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced it has received an expansion of its Emergency Use Authorization (EUA) for the TaqPath COVID-19 Combo Kit to include an additional sample collection method provided by Everlywell, a leading digital health testing company. The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens when determined by a healthcare provider to be appropriate based on results of a COVI
Oct 14, 2020 08:00 am ET
Thermo Fisher Scientific Announces Plans to Expand Sterile Filling Capacity for Therapies and Vaccines with New Facility in Singapore
WALTHAM, Mass., Oct. 14, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development and manufacture of therapies and vaccines.
Aug 05, 2020 08:00 am ET
Thermo Fisher Scientific's COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solution
WALTHAM, Mass., Aug. 5, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing global demand for COVID-19 testing. The high-throughput system enables laboratories to double or even triple their testing capacity to support global efforts to return communities back to work and school.
Aug 04, 2020 04:12 pm ET
Thermo Fisher Scientific Confirms Offer to Acquire QIAGEN Shares Expires on August 10
WALTHAM, Mass., Aug. 4, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today confirmed that its offer to acquire all of QIAGEN's ordinary shares for an increased price of €43.00 per share in cash will expire at 24:00 hours (Frankfurt am Main local time) / 18:00 hours (New York local time) on Monday, August 10, 2020.
Jul 22, 2020 06:00 am ET
Thermo Fisher Scientific Reports Second Quarter 2020 Results
WALTHAM, Mass., July 22, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 27, 2020.
Jul 20, 2020 08:00 am ET
Thermo Fisher Scientific's Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines
WALTHAM, Mass., July 20, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects globally.
Jul 16, 2020 08:45 am ET
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
WALTHAM, Mass. and VENLO, The Netherlands, July 16, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of Sample to Insight molecular diagnostics and sample preparation technologies, today announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN.
Jul 09, 2020 05:00 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., July 9, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per common share, payable on October 15, 2020, to shareholders of record as of September 15, 2020.
Jul 06, 2020 08:00 am ET
Thermo Fisher Scientific Provides Update to Second Quarter Outlook and Will Hold its Q2 Earnings Conference Call on Wednesday, July 22, 2020
WALTHAM, Mass., July 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that, based on currently available information, it estimates that both reported and organic revenue1 growth will be approximately 10% for the second quarter ended June 27, 2020.
May 27, 2020 08:00 am ET
Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software During Virtual ASMS Event
WALTHAM, Mass., May 27, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will provide online programming and virtual exhibits to introduce scientists to a number of new products that build on its leading Orbitrap platform and expand research applications. 
May 27, 2020 05:00 am ET
Thermo Fisher Scientific and CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services
WALTHAM, Mass. and KING OF PRUSSIA, Penn., May 27, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and global biotechnology company, CSL Limited (ASX:CSL;USOTC:CSLLY) today announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies while also accelerating CSL's broader manufacturing objectives.
May 20, 2020 05:00 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., May 20, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per common share, payable on July 15, 2020, to shareholders of record as of June 15, 2020.
May 18, 2020 08:00 am ET
Thermo Fisher Scientific's Support of COVID-19 Response Continues to Expand with U.S. Government Contract for Products Used in Sample Collection
WALTHAM, Mass., May 18, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has received a contract from the U.S. government to provide highly specialized viral transport media (VTM) for COVID-19 sample collection. The VTM is used during collection of patient samples for proper transport to laboratories that can test for the presence of the virus.
May 18, 2020 07:00 am ET
Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V.
WALTHAM, Mass., May 18, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published the offer document (the "Offer Document") for its voluntary tender offer (the "Tender Offer") for all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) at an offer price of €39 per share in cash, following approval of the publication by the German Federal Financial Supervisory Authority.
May 18, 2020 03:15 am ET
Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V.
WALTHAM, Mass., May 18, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published the offer document (the "Offer Document") for its voluntary tender offer (the "Tender Offer") for all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) at an offer price of €39 per share in cash, following approval of the publication by the German Federal Financial Supervisory Authority.
May 14, 2020 08:00 am ET
Helios 5 Laser PFIB Accelerates the Pace of Materials Research for Academic and Industrial Users
HILLSBORO, Ore., May 14, 2020 /PRNewswire/ -- Thermo Fisher Scientific today released the Thermo Scientific Helios 5 Laser PFIB system, an advanced focused ion beam scanning electron microscope (FIB-SEM) with a fully integrated femtosecond laser that quickly characterizes millimeter-scale volumes of material in 3D with nanometer resolution.
May 13, 2020 07:45 am ET
Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test
WALTHAM, Mass., May 13, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic. The new test is the result of ongoing collaboration between all three organizations, including clinical evaluation and support from Mayo Clinic. Thermo Fisher will seek U.S. FDA Emergency Use Authorization (EUA) and international regulatory authorizations for the test over the next few weeks.
May 12, 2020 04:05 pm ET
FDA Further Expands EUA for Thermo Fisher Scientific's COVID-19 Diagnostic Tests
WALTHAM, Mass., May 12, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has further expanded emergency use authorization (EUA) for its multiplex real-time PCR test intended for the qualitative detection of nucleic acid from SARS‑CoV‑2, the virus that causes COVID-19.
May 11, 2020 08:00 am ET
Thermo Fisher Scientific to Double its Capacity of Viral Vector Manufacturing
WALTHAM, Mass., May 11, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more than double the company's commercial viral vector capacity to support increasing demand for the development and manufacture of gene therapies and vaccines.
May 06, 2020 08:00 am ET
Thermo Fisher Scientific to Present at BofA Securities 2020 Health Care Conference
WALTHAM, Mass., May 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will participate in a virtual fireside chat at the BofA Securities 2020 Health Care Conference on Wednesday, May 13, 2020, at 8:20 a.m. (EST). 
Apr 22, 2020 06:00 am ET
Thermo Fisher Scientific Reports First Quarter 2020 Results
WALTHAM, Mass., April 22, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2020.
Apr 06, 2020 08:30 am ET
Thermo Fisher Scientific Provides COVID-19 Business Update and Will Hold First Quarter Earnings Conference Call on Wednesday, April 22, 2020
WALTHAM, Mass., April 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that, due to the evolving COVID-19 pandemic and related customer impact, it is withdrawing 2020 annual guidance, which was provided on January 30, 2020.
Mar 30, 2020 04:05 pm ET
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
WALTHAM, Mass., March 30, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of €1.2 billion aggregate principal amount (the "Offering") of the following euro-denominated notes:
Mar 26, 2020 02:00 am ET
Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19
WALTHAM, Mass., March 26, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19.
Mar 23, 2020 05:30 pm ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
WALTHAM, Mass., March 23, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of $2.2 billion aggregate principal amount (the "Offering") of the following notes:
Mar 17, 2020 09:31 am ET
Thinking about trading options or stock in Caterpillar, Domino's Pizza, Pfizer, Thermo Fisher Scientific, or Trade Desk?
NEW YORK, March 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CAT, DPZ, PFE, TMO, and TTD.
Mar 16, 2020 09:00 am ET
FDA Issued Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19 on March 13
WALTHAM, Mass., March 16, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that on March 13, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens.
Nov 08, 2019 07:00 am ET
Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases
WALTHAM, Mass., Nov. 8, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.19 per share.  The dividend will be paid on January 15, 2020, to shareholders of record as of December 17, 2019.
Oct 23, 2019 06:00 am ET
Thermo Fisher Scientific Reports Third Quarter 2019 Results
WALTHAM, Mass., Oct. 23, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28, 2019.
Oct 01, 2019 06:00 am ET
Thermo Fisher Scientific Completes Acquisition of GSK Manufacturing Site in Cork, Ireland
WALTHAM, Mass., Oct. 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed its previously announced acquisition of an active pharmaceutical ingredient (API) manufacturing facility from GlaxoSmithKline (GSK) for €90 million. Completion of the transaction follows the receipt of all required regulatory approvals.
Sep 30, 2019 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2019
WALTHAM, Mass., Sept. 30, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter of 2019 before the market opens on Wednesday, October 23, 2019, and will hold a conference call on the same day at 8:30 a.m. EDT.
Sep 25, 2019 08:30 am ET
Thermo Fisher Scientific Prices Offering of Senior Notes
WALTHAM, Mass., Sept. 25, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of €4.4 billion aggregate principal amount (the "Euro Offering") of euro-denominated notes (collectively, the "Euro Notes") and an offering of $900 million aggregate principal amount (the "USD Offering" and, together with the Euro Offering, the "Offerings") of USD-denominated notes (collectively, the "USD Notes"). The following notes were priced:
Sep 05, 2019 08:00 am ET
Thermo Fisher Scientific Elects New Director to Board
WALTHAM, Mass., Sept. 5, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has elected Debora Spar to its board of directors. Ms. Spar's appointment brings the company's total number of board members to 13.
Aug 06, 2019 08:05 am ET
Thermo Fisher Scientific Showcases New Innovations for the Clinic During AACC 2019
ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest instruments, assays and software for improving speed, accuracy and usability across clinical and research labs during the 71st American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2019). Thermo Fisher is exhibiting in booth 2110 at the Anaheim Convention Center, Anaheim, Calif., August 4-8.
Jul 24, 2019 06:30 am ET
Thermo Fisher Scientific, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 24, 2019 / Thermo Fisher Scientific, Inc. (NYSE: TMO) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 24, 2019 at 8:30 AM Eastern Time.
Jul 24, 2019 06:00 am ET
Thermo Fisher Scientific Reports Second Quarter 2019 Results
WALTHAM, Mass., July 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29, 2019.
Jul 11, 2019 04:30 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., July 11, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per common share, payable on October 15, 2019, to shareholders of record as of September 17, 2019.
May 23, 2019 04:30 pm ET
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., May 23, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per common share, payable on July 16, 2019, to shareholders of record as of June 14, 2019.
May 20, 2019 04:30 pm ET
Thermo Fisher Scientific to Invest $50 Million to Expand Bioproduction Capabilities
WALTHAM, Mass., May 20, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems.
May 16, 2019 05:00 am ET
Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK
WALTHAM, Mass., May 16, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc (NYSE: GSK) for approximately €90 million in cash. The Cork site will expand capacity to meet customer demand for the development and commercial manufacturing of complex active pharmaceutical ingredients (APIs).
May 07, 2019 08:00 am ET
Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on May 14, 2019
WALTHAM, Mass., May 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 8:40 a.m. (PT) at the Encore at the Wynn Las Vegas, Las Vegas, Nevada.
May 01, 2019 08:30 am ET
Thermo Fisher Scientific Completes Acquisition of Brammer Bio
WALTHAM, Mass., May 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for approximately $1.7 billion in cash.  The completion of the transaction follows the receipt of all required regulatory approvals.
Apr 29, 2019 04:05 pm ET
Thermo Fisher Scientific to Host Analyst Meeting
WALTHAM, Mass., April 29, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2019 Analyst Meeting on Wednesday, May 22, starting at 9:00 a.m. (ET), at the Park Hyatt New York, 153 West 57th Street, in New York City.
Apr 24, 2019 06:00 am ET
Thermo Fisher Scientific Reports First Quarter 2019 Results
WALTHAM, Mass., April 24, 2019 /PRNewswire/ --  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2019.
Apr 01, 2019 08:00 am ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2019
WALTHAM, Mass., April 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter of 2019 before the market opens on Wednesday, April 24, 2019, and will hold a conference call on the same day at 8:30 a.m. EDT.
Mar 27, 2019 07:00 am ET
Research Report Identifies Alamos Gold, Thermo Fisher Scientific, Veracyte, Air Lease, Carlisle Companies, and Medidata Solutions with Renewed Outlook — Fundamental Analysis, Calculating Forward Movem
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alamos Gold Inc. (NYSE:AGI), Thermo Fisher Scientific Inc. (NYSE:TMO),...
Mar 24, 2019 08:30 pm ET
Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing
WALTHAM, Mass. and CAMBRIDGE, Mass., March 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, today announced they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately $1.7 billion in cash.
Mar 19, 2019 08:35 am ET
Thermo Fisher Scientific Innovations at Pittcon 2019 Enable Workflows Across Life Sciences, Applied and Industrial Markets
PHILADELPHIA, March 19, 2019 /PRNewswire/ -- Pittcon 2019 -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is introducing innovative products, software and services for customers working in biopharma, food safety, environmental quality and industrial applications during the 2019 Pittcon Conference and Exhibition. The company will showcase analytical workflows that enable fast, precise analyses within booth #2632 at the Philadelphia Convention Center, March 17 - 21, 2019.
Mar 18, 2019 09:00 am ET
Thermo Fisher Scientific to Invest $150 Million to Expand Pharma Services Capabilities
WALTHAM, Mass., March 18, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
Mar 04, 2019 07:00 am ET
Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 13, 2019
WALTHAM, Mass., March 4, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019, at 8:00 a.m. (EDT) at the Loews Miami Hotel, Miami, Florida.
Feb 26, 2019 03:30 pm ET
Thermo Fisher Scientific Increases Quarterly Dividend
WALTHAM, Mass., Feb. 26, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.19 per common share, payable on April 16, 2019, to shareholders of record as of March 15, 2019. This reflects a 12% increase over the previous dividend payment of $0.17.
Feb 04, 2019 07:00 am ET
Torque and Thermo Fisher Scientific Announce Collaboration to Build State-of-the-Art Facility to Manufacture Torque's Deep-Primed T Cell Immunotherapies
CAMBRIDGE, Mass. and WALTHAM, Mass., Feb. 4, 2019 /PRNewswire/ -- Torque, an immuno-oncology company developing first-in-class Deep Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, and Thermo Fisher Scientific Inc. (NYSE: TMO), today announced a collaboration to build a dedicated Slipstream™ manufacturing facility for high-efficiency production of Torque's Deep-Primed T cell immunotherapies.
Feb 01, 2019 07:55 am ET
Factors of Influence in 2019, Key Indicators and Opportunity within Rexnord, Carlisle Companies, Acorda Therapeutics, Valmont Industries, Reliance Steel & Aluminum, and Thermo Fisher Scientific — New
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Rexnord Corporation (NYSE:RXN), Carlisle Companies Incorporated...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.